Original document(15 pages) Authorized document(15 pages) 中文版
    A Chinese medicine for treating chronic gastritis is composed of the oral liquid prepared from 7 Chinese-medicinal materials including trichosanthes fruit, safflower, astragalus root, liquorice root, etc and the capsule prepared from sandal wood, eagle wood, aucklandia root, dalbergia wood and frankincense.
Application Number
申请号		 200510136696 Application Date
申请日		 2005.12.30
Title 名称 Chinese medicinal preparation for treating chronic gastritis using spleen fortifying oral liquid and stomach fortifying capsule combined treatment
Publication Number
公开号		 1824254 Publication Date
公开日		 2006.08.30
Approval Pub. Date 2007.10.10 Granted Pub. Date 2007.10.10
International Classification 分类号 A61K36/906;A61K36/902;A61K36/896;A61K36/835;A61K36/484;A61K36/481;A61K36/48;A61K36/324;A61K36/286;A61K36/285;A61K36/284;A61K36/185;A61K9/08;A61K9/10;A61K9/48;A61P1/04;A61K35/24
Applicant(s) Name
申请人		 Zhang Shuya
Address 地址
Inventor(s) Name 发明人 Zhang Shuya
Attorney & Agent 代理人 yang zhongyi

  
Real-time fluorescent inspection and reagent kit for Norwalk virus in mussel
Curcuma zedoary oil solid lipid nano-particle and its preparation method
Chinese medicinal preparation for treating osteopathia and its preparation method
Uterus stabilizing pressure reducing medicinal preparation and its new peparation method
Quality control method of fuyuekang Chinese medicinal preparation
Chinese medicinal preparation for treating woman menstrual pain and its preparation method
Medicine for treating disease due to kidney yang vacuity
Soaking agent for foot health care
Chinese medicinal preparation for treating atrophic arthritis
Preparation method of medicine possessing spirit quieting brain supplementing action
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.